Pigmentation Disorders Treatment Market was valued at US$ 6,087.0 Mn in 2021 and is forecast to reach a value of US$ 9,678.6 Mn by 2028 at a CAGR of 6.9% between 2023 and 2028 | Abbvie Inc. (Allergan Inc.), Episciences Inc., L’ORÉAL SA (SkinCeuticals International)

The market for pigmentation disorder treatment (PDT) worldwide was priced at US 6,087.0 million in the year 2021 and is predicted to the extent of US 9,678.6 million by the end of year 2028 at CAGR of 6.9% from 2022 to 2028. The market for the treatment in pigmentation disorder worldwide is witnessing robust development owing to the increase in incidence of pigmentation disorders and rising elderly population worldwide. Furthermore, increase in the need for safe, efficient and accurate treatment and the rising consciousness amongst the people about pigmentation disorder is anticipated to fuel the market growth. Though, certain issues like cost of related treatments is quite high and absent of reimbursement policies are anticipated to hinder the market growth of the treatment in pigmentation disorders.

Get Research Sample PDF with Market Development Insights @ https://www.coherentmarketinsights.com/insight/request-sample/5421

Global Pigmentation Disorders Treatment Market: Regional Insights_MI

On the basis of geography, the market of PDT is divided into Europe, Middle East & Africa, North America, Latin America and Asia Pacific.

On the basis of regions, North America is anticipated to have the major portion of the share of the market in the predicted period owing to the rising incidence of pigmentation disorders and the rising populations of the elderly people in this region. For example, the elderly population is susceptible to few pigmentation disorders or few pigmentation disorders are dominant among the elderly population. As per the report 20022 of U.S. Census Bureau, about 5 million elders of age 65 years and above live in the U.S. reporting for over 16.9% of the population of the nation. By the end of 2030, it is estimated that the number of older adults will be 73.1 million. This results in pushing the growth of the market.

Europe and Asia Pacific are anticipated to experience strong development in the market of PDT worldwide owing to the increase in incidence of pigmentation disorders and the elderly population in the region. For example, disorders in pigmentation are prevailing in the elderly people. Asia and Europe are ranking high in the population of the world for the oldest people, aged 65 and above. As per report of July 2022 of United Nations Economic and Social Commission for Asia and the Pacific, the number of people of age 65 and above is 630 million, signifying 60% of the older person in the world. By 2050, the figure is estimated to reach and rise to 1.3 billion.

Global Pigmentation Disorders Treatment Market Drivers_MI

Increase in incidence of the disorders in pigmentation across the world is anticipated to increase the development of the market of the treatment of pigmentation disorder worldwide in the predicted period. For example, pigmentary disorders like vitiligo, melasma, and lentigo have major negative effect on the health-associated quality of life. Therefore, there is demand for safe, efficient, and accurate treatment on the basis of incidence and impact on the life’s quality. The FDA or the Food and Drug Administration approved a cream approvedruxolitinib (Opzelura) for treating non-segmental vitiligo in adults as well as in the child patients of age 12 years and more.

Increasing population of the elderly people across the world is anticipated to enhance the market for the treatment in pigmentation disorder worldwide in the predicted period. For example, the elderly population is more susceptible to get the pigmentary disorders, since skin that age develops avascular and the skin of the elderly gets marked by pallor. As per Who (World Health Organization), by the end of 2030, 1 in every 6 people around the world wil be of age 60 years and above, and the population of the people in the world will age 60 years and above which is around 2.1 million by the end of the year 2050. This is anticipated to help in the development of the market of treatment of pigmentation disorder worldwide.

Global Pigmentation Disorders Treatment Market Opportunities_MI

Increase in the need for safe, efficient and accurate treatment is anticipated to provide opportunities of growth for the companies in the market for PDT. For example, Clinuvel Pharmaceuticals in May 2022 pronounced that a novel prospective therapy will be undertaken in North America for the study of pigmentation loss disorder vitiligo. Approved by US and European regulators approved the drug afamelanotide, for light intolerance disorder, is being assessed by Clinuvel Pharmaceuticals for treating vitiligo patients with skins of dark types.

Direct Purchase This Report with Huge Discount ( Up To 25% Off) @ https://www.coherentmarketinsights.com/insight/buy-now/5421

Rising consciousness amongst people about disorders of pigmentation is anticipated to provide opportunities of growth for the companies in the market for PDT. For example, with the increasing consciousness amongst the world population, the need for safe, efficient and accurate treatment is rising very fast. Therefore, the companies operating in the market are emphasizing on the expansion and the introduction of a new treatments in the market. Uniza Group in October 2021 introduced the launch of new solution for the Vitiligo management in the market of India.

Global Pigmentation Disorders Treatment Market Trends_MI

The main fashion in the market for the treatment of pigmentation disorder is the rising emphasis on the growth of sale and the efficacy in the treatment of pigmentation disorder. The companies in the market are emphasizing on the expansion and the introduction of safe, efficient and accurate treatments owing to the rise in incidence of disorders in pigmentation and rise in need for new treatments. This is anticipated to last in the predicted period, pushing the growth of the market.

Furthermore, the rising consciousness amongst people about the several dermatological disorders resulted in the rise of spending of treatments for dermatological reasons which is in addition linked with increase in the quality of life and the per capita levels of income worldwide. This result in the increase in spending on treatments for dermatological reasons, fuelling the development of the market growth of PDT worldwide in the predicted period.

Global Pigmentation Disorders Treatment Market Restraints_MI

The high expenditure related with the treatment is anticipated to hinder the market growth of the treatment of pigmentation disorder worldwide. For example, the cost of treatment for pigmentation is dependent on the kind of treatment and the required number of appointments needed to rectify the skin tone. In India, the laser treatment cost for the pigmentation varies from Rs 5.000 to 8, 000 per sitting. Though, the total cost changes on the basis of factors like pigmentation strength, type of skin, the part of the kin that is to treated,  and other related underlying health disorders  amongst others.

Absence of policies for reimbursements is anticipated to hamper the market growth of the PDT worldwide. For example, reimbursement is given for the expenditure and treatments carried out medically, whereas in disorders for pigmentation and its treatment, the expenditures are not covered by any policy. As the insurance companies do not take any initiative in covering these expenses, it has to be solely born by the patient which poses a threat to the market.

Global Pigmentation Disorders Treatment Market Segmentation_MI

Globally, the market for treatment of pigmentation disorder is divided into type of disorder, treatment type and geography.

On the basis of type of disorder, the market for treatment of pigmentation disorder worldwide is divided into Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation (PIH), Melasma and other types of disorders. Among which, the segment of Albinism is anticipated to control the market of PDT in the predicted period and this is credited to the increase in the albinism cases which is a class of rare genetic disorder causing discoloring of skin, hair and eyes.

The segment of vitiligo is anticipated to experience substantial development in the coming future and this is due to the rise in incidence of disorders of pigmentation like vitiligo.

On the basis of treatment type, the market for treatment of pigmentation disorder is divided into topical treatment, chemical peels, dermabrasion, phototherapy, laser treatment and other types of treatments. Among which, the segment for topical treatment is anticipated to control the market in the predicted period and this accredited to the rise in need for treatments in topical.

The segment for dermabrasion is anticipated to experience substantial development in the coming future and this owing to the rise in incidence of disorder for pigmentation. Dermabrasion is a method which involves safe and efficient procedures for cosmetic skincare. Vitiligo gets re-pigmented by vitiligo.

Global Pigmentation Disorders Treatment Market: Key Developments_MI

National Organization for Albinism and Hypopigmentation in June 2021 pronounced a proposal call, emphasizing on exclusive research for therapeutics and biomarkers progress for all kinds of albinism with a fund value of US$ 100,000.

Adventist Development and Relief Agency’s (ADRA) in September 2020 started an Innovation Program for treatment of cryosurgery cancer for albinism patients in Tanzania.

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5421

Clinuvel Pharmaceuticals in May 2020 appeared at a Type C meeting with the U.S Food Drug and Administration and clinical experts of the world in vitiligo to converse the North American development program for SCENESSE (afamelanotide 16mg) for vitiligo treatment.

Global Pigmentation Disorders Treatment Market: Key Companies Insights_MI

Globally, the market for the treatment of pigmentation disorder is very much competitive in nature.This is accredited to the rise in need for safe, efficient and accurate treatments, consequently, companies in the market are emphasizing on the launch of new treatments.

The main companies in the market for the treatment of pigmentation disorder globally  includes Abbvie Inc. (Allergan Inc.), Episciences Inc., L’ORÉAL SA (SkinCeuticals International), and Pfizer Inc.

Table of Contents:

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Type of Disorder
     • Market Snapshot, By Treatment Type
     • Market Snapshot, By Geography
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Rise in prevalence of pigmentation disorders
     • High cost associated with the treatment
     • Rise in demand for safe & effective treatment
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product launch/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
4. Global Pigmentation Disorders Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Pigmentation Disorders Treatment Market, By Type of Disorder, 2017-2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2022 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Albinism
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Vitiligo
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Melasma
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Post-Inflammatory Hyperpigmentation (PIH)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Other Types of Disorders
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Pigmentation Disorders Treatment Market, By Treatment Type, 2017-2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2022 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Topical Treatment
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Dermabrasion
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Chemical peels
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Laser Treatment
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Phototherapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
   • Other Treatment Types
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)